0.65
0.65 (0%)
As of Feb 14, 2025
Applied Therapeutics Inc. [APLT]
Source:
Company Overview
Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. We focus on molecules and pathways whose role in the disease process is well known based on prior research, but have previously failed to yield successful products due to poor efficacy and tolerability.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | 212-220-9319 |
| Industry | manufacturing |
| CEO | Shoshana Shendelman, Ph.D. |
| Website | www.appliedtherapeutics.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.1 |
| Operating Profit | $-20.4 |
| Net Income | $2.9 |
| Net Cash | $72.3 |
Profit Ratios
| Gross Margin | $0.1 |
| Operating Margin | -14,194.4 |
| Profit as % of Revenues | 5% |
| Profit as % of Assets | 4.5% |
| Profit as % of Stockholder Equity | 4% |
Management Effectiveness
| Return on Equity | 4% |
| Return on Assets | 2.3% |
| Turnover Ratio | 0.2% |
| EBITA | $-20.4 |
Balance Sheet and Cash Flow Measures
| Total Assets | $127.8 |
| Total Liabilities | $55.4 |
| Operating Cash Flow | $-41.5 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $113.8 |
